Related Experiment Video

Updated: May 4, 2026

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms
08:16

Author Spotlight: Advancing Type 1 Diabetes Research Using Innovative Pancreatic Slice Platforms

Published on: March 15, 2024

2.1K

[Technological advances in the treatment of type 1 diabetes in pediatric patients]

N Tubiana-Rufi1

  • 1Service d'endocrinologie et de diabétologie pédiatrique, hôpital Robert-Debré (AP-HP), 48 boulevard Sérurier, 75019 Paris, France.

Archives De Pediatrie : Organe Officiel De La Societe Francaise De Pediatrie
|December 24, 2013
PubMed

Insights

Recent innovations like insulin pumps and continuous glucose monitoring offer advanced management for pediatric type 1 diabetes. While strict glycemic control is vital, it carries a significant risk of hypoglycemia, especially severe episodes.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Biomedical Engineering

Context:

  • Type 1 diabetes (T1D) management in children requires precise glycemic control to prevent long-term complications.
  • Technological advancements are transforming T1D care, offering new tools for patients and clinicians.
  • The integration of insulin pumps and continuous glucose monitoring (CGM) systems represents a significant leap forward.

Purpose:

  • To review the latest innovations in pediatric type 1 diabetes management.
  • To highlight the potential of combined insulin pump and CGM technology towards an artificial pancreas.
  • To discuss the critical balance between glycemic control and the risk of hypoglycemia in T1D.

Summary:

  • The latest advancements for pediatric type 1 diabetes include sophisticated insulin pumps with enhanced functionalities and continuous glucose monitoring (CGM) devices.
  • The combination of insulin pumps and CGM systems is paving the way for the development of an artificial pancreas, offering more automated glycemic regulation.
  • While stringent control of blood glucose levels is essential for preventing diabetes-related complications, it is associated with an increased risk of hypoglycemic episodes, particularly severe ones.

Impact:

  • These innovations promise improved quality of life and better health outcomes for children with type 1 diabetes.
  • The development of the artificial pancreas could revolutionize T1D management, reducing the burden of daily self-care.
  • Addressing the risk of hypoglycemia remains a critical challenge in optimizing T1D treatment strategies.

More Related Videos

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

5.3K
Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

2.1K

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.5K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.5K
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1...
45
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular...
75
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the...
26
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.9K